1.Clinical research of cold therapy in treatment of inflammatory hemorrhoids
Qinglun SU ; Xiyang ZHOU ; Qin ZHAO ; Hongyan WANG ; Yonggang ZHU ; Zhen LIU
Chinese Journal of Postgraduates of Medicine 2012;35(11):19-21
ObjectiveTo explore the clinical effects of cold therapy in treatment of inflammatory hemorrhoids.MethodsSixty patients were separated into two groups according to the visiting sequence with 30 cases each.The treatment group accepted cold therapy,meanwhile the control group took the tablets diosmin and accepted hot compress with 50% magnesium sulfate.ResultsThe symptoms evaluation score was ( 10.5 ± 1.3 ) scores and (6.4 ± 1.2) scores before and after treatment in treatment group,while ( 10.3 ±1.4) scores and(9.4 ± 1.3) scores in control group,there was no significant difference before treatment between two groups (P> 0.05 ),but there was significant difference after treatment between two groups (P<0.05).After 3 days treatment,cure rate was 60.0%(18/30),eifficient rate was 90.0%(27/30) in treatment group,while 10.0% (3/30),53.3% ( 16/30 ) in control group,there were significant differences between two groups(P< 0.05).ConclusionCold therapy is good for inflammatory hemorrhoids.
2.Deciphering chemical and metabolite profiling of Chang-Kang-Fang by UPLC-Q-TOF-MS/MS and its potential active components identification.
Fengge YANG ; Sihao ZHANG ; Danmei TIAN ; Guirong ZHOU ; Xiyang TANG ; Xinglong MIAO ; Yi HE ; Xinsheng YAO ; Jinshan TANG
Chinese Journal of Natural Medicines (English Ed.) 2023;21(6):459-480
Chang-Kang-Fang (CKF) formula, a Traditional Chinese Medicine (TCM) prescription, has been widely used for the treatment of irritable bowel syndrome (IBS). However, its potential material basis and underlying mechanism remain elusive. Therefore, this study employed an integrated approach that combined ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS) with network pharmacology to systematically characterize the phytochemical components and metabolites of CKF, as well as elucidating its underlying mechanism. Through this comprehensive analysis, a total of 150 components were identified or tentatively characterized within the CKF formula. Notably, six N-acetyldopamine oligomers from CicadaePeriostracum and eight resin glycosides from Cuscutae Semen were characterized in this formula for the first time. Meanwhile, 149 xenobiotics (58 prototypes and 91 metabolites) were detected in plasma, urine, feces, brain, and intestinal contents, and the in vivo metabolic pathways of resin glycosides were elaborated for the first time. Furthermore, network pharmacology and molecular docking analyses revealed that alkaloids, flavonoids, chromones, monoterpenes, N-acetyldopamine dimers, p-hydroxycinnamic acid, and Cus-3/isomer might be responsible for the beneficial effects of CKF in treating IBS, and CASP8, MARK14, PIK3C, PIK3R1, TLR4, and TNF may be its potential targets. These discoveries offer a comprehensive understanding of the potential material basis and clarify the underlying mechanism of the CKF formula in treating IBS, facilitating the broader application of CKF in the field of medicine.
Humans
;
Tandem Mass Spectrometry/methods*
;
Irritable Bowel Syndrome/drug therapy*
;
Molecular Docking Simulation
;
Drugs, Chinese Herbal/chemistry*
;
Glycosides
;
Chromatography, High Pressure Liquid/methods*